NewcelX Stock (NASDAQ:NCEL)
Previous Close
$2.71
52W Range
$2.48 - $33.70
50D Avg
$6.96
200D Avg
$16.53
Market Cap
$1.17M
Avg Vol (3M)
$205.66K
Beta
0.57
Div Yield
-
NCEL Company Profile
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.